CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 


Blueprint Medicines Corp  (BPMC)
Other Ticker:  
 
    Sector  Healthcare    Industry Major Pharmaceutical Preparations
 

Blueprint Medicines's Gross Margin by quarter

Trends, Rankings, Statistics

Select the Comparisons : Select the Ratio:                        

BPMC Gross Margin (Mar 31 2017)
I. Quarter
(Dec 31 2016)
IV. Quarter
(Sep 30 2016)
III. Quarter
(Jun 30 2016)
II. Quarter
(Mar 31 2016)
I. Quarter
Y / Y Revenue Change -14.82 % - 79.8 % 162.93 % 951.53 %
Y / Y Gross Profit Change - - - - -
Gross Margin - - - - -
Gross Margin Total Ranking # 507 # 818 # 612 # 668 # 663
Seq. Revenue Change -24.07 % 24.85 % -12.81 % 3.05 % -
Seq. Gross Profit Change - - - - -


Commenting First Quarter 2017 Gross Margin
Blueprint Medicines Corp experienced contraction in Gross Profit by -24.07 % to $6 millions and Revenue by -24.07 %, while Gross Margin fell to 100 % a new company low.

Observing first quarter 2017 results within Major Pharmaceutical Preparations industry 70 other companies have achieved higher Gross Margin. While Gross Margin total ranking has impoved so far to 507, from total ranking in previous quarter at 818.
Learn about Gross Margin
BPMC's Gross Margin first quarter 2017 Company Ranking
Within: No.
Industry # 71
Sector # 142
S&P 500 # 507

Gross Margin Statistics
High Average Low
100 % 100 % 100 %
(Mar 31 2017)  

You need to upgrade your Flash Player


Financial Statements
Blueprint Medicines's (Mar 31 2017) Gross Profit $ 6 BPMC's Income Statement
Blueprint Medicines's (Mar 31 2016) Gross Profit $ 7 Quarterly BPMC's Growth
BPMC's Profits by Division See BPMC's Profits by Segment

Other Gross Margin Profitability Ratios
BPMC's Cumulative Gross Margin
Major Pharmaceutical Preparations Industry Gross Margin Trends and Statistics
Healthcare Sector Gross Margin Statistics
Gross Margin Profitability Trends for overall market
BPMC's Gross Margin Profitability versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Gross Margin
Lowest Ranking Gross Margin
Gross Margin Profit Margin for BPMC's Competitors
Gross Margin Profit Margin for Blueprint Medicines's Suppliers
Gross Margin Profit Margin for BPMC's Customers

You may also want to know
BPMC's Annual Growth Rates BPMC's Profitability Ratios BPMC's Asset Turnover Ratio BPMC's Dividend Growth
BPMC's Roe BPMC's Valuation Ratios BPMC's Financial Strength Ratios BPMC's Gross Profit Growth
BPMC's Roa BPMC's Inventory Turnover Ratio BPMC's Growth Rates BPMC's Dividend Comparisons


Companies with similar Gross Margin in the quarter ending Mar 31 2017, within Major Pharmaceutical Preparations Industry Gross MarginMar 31 2017 MRQ Gross ProfitMar 31 2017 MRQ Revenue
Oncomed Pharmaceuticals Inc  100.00 %$ 6.213 $ 6.213 
Corbus Pharmaceuticals Holdings, Inc.  100.00 %$ 1.294 $ 1.294 
Onconova Therapeutics, Inc.  100.00 %$ 0.210 $ 0.210 
Northwest Biotherapeutics Inc  100.00 %$ 0.068 $ 0.068 
Novan, Inc.  100.00 %$ 0.100 $ 0.100 
Newlink Genetics Corp  100.00 %$ 2.761 $ 2.761 
Dicerna Pharmaceuticals Inc  100.00 %$ 0.133 $ 0.133 
Dermira, Inc.  100.00 %$ 1.066 $ 1.066 
Ophthotech Corp.  100.00 %$ 1.662 $ 1.662 
Progenics Pharmaceuticals Inc  100.00 %$ 2.347 $ 2.347 
Celsion Corp  100.00 %$ 0.125 $ 0.125 
Clearside Biomedical, Inc.  100.00 %$ 0.005 $ 0.005 
Checkpoint Therapeutics, Inc.  100.00 %$ 0.693 $ 0.693 
Paratek Pharmaceuticals, Inc.  100.00 %$ 0.018 $ 0.018 
Chimerix Inc  100.00 %$ 1.078 $ 1.078 
Pharmathene, Inc  100.00 %$ 0.804 $ 0.804 
Prothena Corp Plc  100.00 %$ 0.259 $ 0.259 
Conatus Pharmaceuticals Inc.  100.00 %$ 6.998 $ 6.998 
Dynavax Technologies Corp  100.00 %$ 0.148 $ 0.148 
Eleven Biotherapeutics, Inc.  100.00 %$ 0.425 $ 0.425 
Geron Corp  100.00 %$ 0.537 $ 0.537 
Five Prime Therapeutics Inc  100.00 %$ 10.135 $ 10.135 
Ionis Pharmaceuticals Inc  100.00 %$ 110.304 $ 110.304 
Abeona Therapeutics Inc.  100.00 %$ 0.186 $ 0.186 
Genvec Inc  100.00 %$ 0.114 $ 0.114 
Ibio, Inc.  100.00 %$ 0.037 $ 0.037 
Heat Biologics, Inc.  100.00 %$ 0.024 $ 0.024 
Immunogen Inc  100.00 %$ 28.499 $ 28.499 
Intra-cellular Therapies, Inc.  100.00 %$ 0.095 $ 0.095 
Fibrogen Inc  100.00 %$ 26.891 $ 26.891 
Economy

Advance Monthly Sales
Consumer Price Index CPI
Producer Price Index PPI
Retail Inventories
Personal Income
Gross Domestic Product GDP
Money Supply
Industrial Production
Productivity
Employment Situation
US International Trade
Factory Orders
Durable Goods
Construction Spending
Housing Starts
Vehicle Unit Sales
Stocks

Event Calendar
USAC's Profile
Stock Price
USAC's Financials
USAC's Expectations
Business Description
Fundamentals
Charts & Quotes
USAC's News
Suppliers
USAC's Competitors
Customers & Markets
Economic Indicators
USAC's Growth
Company Segments
Industries

At a Glance
Performance
Growth Rates
Profitability
Valuation
Financial Strength
Markets

At a Glance
Stocks
Indices
Sectors & Industries
Financials
Commodities
Currencies
Screening

Stock Performance
Growth Rates
Profitability
Valuation
Dividend
Financial Strength
Efficiency
Expectations
Management Effectivness
News

At a Glance
Stocks
Economy
Industries
Other
Glossary

Financial Terms
Technical Analysis
Fundamental Analysis
Energy Terms
Manufacturing Terms
Transportation Terms
Health Care
Insurance Terms
Economy Terms
Hotel & Leisure Terms
Help

Sitemap
Advertise
About us
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2017 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com